Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Entera Bio Ltd. Ordinary Shares (ENTX)

Biological Products, (no Disgnostic Substances)

https://www.enterabio.com

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR
JERUSALEM, L3

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/28/2018

Market Cap

58,482,606

Shares Outstanding

28,810,000

Weighted SO

36,730,831

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

NLSP --.--%

VCNX --.--%

ATHE --.--%

ENOB --.--%

IMMP --.--%

Beta

1.6070

Last Div

0.0000

Range

0.52-3.35

Chg

0.0100

Avg Vol

64546

Mkt Cap

58482606

Exch

NASDAQ

Country

IL

Phone

972 2 532 7151

DCF Diff

1.2636

DCF

0.3664

Div Yield

0.0000

P/S

12.8845

EV Multiple

-5.8210

P/FV

6.9990

Div Yield %

0.0000

P/E

-6.9957

PEG

-0.2249

Payout

0.0000

Current Ratio

7.4150

Quick Ratio

7.4150

Cash Ratio

7.0587

DSO

10.1322

DIO

0.0000

Op Cycle

10.1322

DPO

286.1932

CCC

-276.0610

Gross Margin

0.9806

Op Margin

-1.8916

Pretax Margin

-1.8742

Net Margin

-1.8806

Eff Tax Rate

-0.2485

ROA

-0.8506

ROE

-1.0037

ROCE

-0.9823

NI/EBT

1.0034

EBT/EBIT

0.9908

EBIT/Rev

-1.8916

Debt Ratio

0.0333

D/E

0.0391

LT Debt/Cap

0.0205

Total Debt/Cap

0.0377

Int Coverage

-268.3125

CF/Debt

-21.5696

Equity Multi

1.1762

Rec Turnover

36.0238

Pay Turnover

1.2754

Inv Turnover

0.0000

FA Turnover

10.8071

Asset Turnover

0.4523

OCF/Share

-0.1942

FCF/Share

-0.1944

Cash/Share

0.2463

OCF/Sales

-1.5872

FCF/OCF

1.0006

CF Coverage

-21.5696

ST Coverage

-46.4790

CapEx Coverage

-1567.3959

Div&CapEx Cov

-1567.3959

P/BV

6.9990

P/B

6.9990

P/S

12.8845

P/E

-6.9957

P/FCF

-8.1126

P/OCF

-8.2889

P/CF

-8.2889

PEG

-0.2249

P/S

12.8845

EV Multiple

-5.8210

P/FV

6.9990

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation